The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
1CM Inc. is a retailer of vice consumer staples in Canada including Cannabis, Alcohol, Tobacco, Nicotine Vape, and CPG (Consumer Packaged Goods). Our vision is to be Canada's leading vice consumer staples retailer and wholesaler. The Company is focused on expanding its current operations through organic growth and by way of merger and acquisition transactions.
4Front Ventures Corp. is a vertically-integrated cannabis company with cultivation, production and retail facilities spread across several states in the US.
Share Classes
4Front has two classes of shares: subordinate voting shares (“SVS”) and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote. MVS are not publicly traded, can convert to SVS at a ratio of 1 MVS to 1 SVS, and are entitled to 800 votes per MVS.
There are 913,928,993 SVS outstanding and 1,276,208 MVS convertible to 1,276,208 outstanding for a total outstanding SVS of 915,205,201 on an as-converted basis.
Please see Section 10 - Description of Securities of 4Front's Form 2A Listing Statement for a further description of the SVS and MVS.
Founded in 2014, Adastra Holdings Ltd. through its Health Canada licensed subsidiary, Adastra Labs has built a successful reputation as a leading cannabis processor. Adastra manufactures products for its successful in-house concentrates brands Phyto Extractions and Endgame Extracts and co-manufactures for many Canadian cannabis brands. With products sold at more than 2,000 retailers across the country.
Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing and co-located analytical testing lab facility, Adastra produces and distributes cannabis-derived products designed for medical cannabis and forward-looking therapeutic use.
Adastra received its controlled substances dealer's license in August 2022 with an amendment in February 2023 and is licensed to partner with healthcare professionals and practitioners within the regulated environment to help create efficacious remedies that address the actual needs of patients.
Affinor is focused on the design, development and commercialization of vertical farming technology for both indoor and outdoor (greenhouse) applications. The team is currently working on demand crops such as romaine lettuce and strawberries by developing processes, methods and models to cultivate true perpetual crops at competitive pricing. It is the mission of Affinor to be the world-wide technology and market leader in creating and commercializing the most economical vertical farming technologies that use the least possible resources (eg. land, water, and energy resources) to produce the highest quality pesticide-free produce year-round, regardless of environmental conditions. Affinor’s patent technology and licensed patent pending technology positions the Company well in the vertical farming industry. It is the only vertically integrated technology that can offer patented inline automated pollination for fruiting crops. Affinor can offer software driven growing solutions automating high quality, scientifically engineered products and process.
The Issuer is a digital health solutions provider utilizing a proprietary combination of digital health monitoring devices, AI based software, and a cloud computing platform which combine to help care givers, patients and healthcare professionals access and utilize relevant health data.
Aion Therapeutic is a forward-thinking business within the health and wellness sector with a diverse portfolio of intellectual property. With a commitment to innovation and transformative solutions, the Company is poised to drive positive change to redefine the boundaries of health and wellness.
Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.
Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Ascend Wellness Holdings, Inc. (AWH) is a multi-state operator with assets and partners in Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. AWH owns and operates state-of-the-art cultivation facilities, growing award winning strains and producing a curated selection of products. AWH produces and distributes its in-house Ozone, Ozone Reserve, and Simply Herb branded products.
Asep Medical Holdings Inc. (asepmedical.com) is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine. The Company is a consolidation of three existing private companies all with technology in advanced development — Sepset Biosciences Inc. (proprietary diagnostic tools to enable the early and timely identification of sepsis), ABT Innovations Inc. (broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections), and SafeCoat Medical Inc. (an antibacterial peptide medical device coating technology).
